Switching to or onboarding a new API supplier introduces risk that experienced procurement teams work hard to manage, yet certain mistakes still recur across the industry. Recognizing these mistakes sourcing APIs from new suppliers helps buyers avoid costly setbacks.

Skipping Independent Sample Verification

Relying solely on a new supplier’s own Certificate of Analysis, without independent testing of sample material, is a common and risky shortcut. Supplier-reported data can occasionally contain errors or reflect testing conditions that don’t fully represent the material a buyer will actually receive at commercial scale.

Underestimating the Time Required for Proper Qualification

Rushing supplier qualification to meet an aggressive project timeline often backfires, since inadequately vetted suppliers are more likely to cause disruptions later. Building realistic qualification timelines into project planning from the outset helps avoid this pressure-driven shortcut.

Not Confirming Regulatory Documentation Early

Discovering that a new supplier’s DMF filing is outdated or doesn’t cover the intended use only after finalizing a sourcing agreement can force a costly, time-consuming supplier change mid-project. Confirming regulatory documentation status should happen during initial supplier evaluation, not after commitment.

Overlooking Scale-Up Capacity Beyond Initial Samples

A supplier capable of producing high-quality sample batches doesn’t automatically have the capacity to reliably support commercial-volume production. Buyers should specifically confirm scale-up capability and request evidence of the supplier’s track record at the volumes actually needed.

Failing to Establish Clear Quality Agreements

Proceeding without a formal quality agreement, clearly defining specifications, change notification requirements, and responsibilities for deviation handling, creates ambiguity that can cause significant problems if quality issues arise later in the relationship.

Single-Sourcing Without a Backup Plan

Relying entirely on a single new supplier without qualifying any backup option creates meaningful supply chain vulnerability. If the new supplier experiences quality issues, capacity constraints, or business disruption, buyers without a backup face significant production risk with no immediate alternative.

Not Building in a Transition or Overlap Period

Switching entirely to a new supplier without an overlap period, where both old and new supply sources run in parallel briefly, removes the safety net that would otherwise allow buyers to catch problems with the new source before fully depending on it.

Frequently Asked Questions

Why is independent sample testing important even with a supplier’s own Certificate of Analysis?
Independent testing verifies that supplier-reported data accurately reflects the actual material quality, catching potential discrepancies or testing condition differences that supplier documentation alone might not reveal.

Should buyers maintain a backup API supplier even after qualifying a new primary source?
Yes, relying on a single supplier without a qualified backup creates significant vulnerability to quality issues, capacity constraints, or business disruption affecting that sole source.

Contact Our Team

We support pharmaceutical buyers with transparent documentation and reliable supply to reduce risk when qualifying a new API sourcing relationship.

Contact us today to discuss your sourcing needs.